167 related articles for article (PubMed ID: 16687609)
21. Contribution of both the sarcolemmal K(ATP) and mitochondrial K(ATP) channels to infarct size limitation by K(ATP) channel openers: differences from preconditioning in the role of sarcolemmal K(ATP) channels.
Tanno M; Miura T; Tsuchida A; Miki T; Nishino Y; Ohnuma Y; Shimamoto K
Naunyn Schmiedebergs Arch Pharmacol; 2001 Sep; 364(3):226-32. PubMed ID: 11521165
[TBL] [Abstract][Full Text] [Related]
22. Essential role of mitochondrial Ca2+-activated and ATP-sensitive K+ channels in sildenafil-induced late cardioprotection.
Wang X; Fisher PW; Xi L; Kukreja RC
J Mol Cell Cardiol; 2008 Jan; 44(1):105-13. PubMed ID: 18021798
[TBL] [Abstract][Full Text] [Related]
23. Difference in the cardioprotective mechanisms between ischemic preconditioning and pharmacological preconditioning by diazoxide in rat hearts.
Wakahara N; Katoh H; Yaguchi Y; Uehara A; Satoh H; Terada H; Fujise Y; Hayashi H
Circ J; 2004 Feb; 68(2):156-62. PubMed ID: 14745152
[TBL] [Abstract][Full Text] [Related]
24. Cardioprotective effects of BMS-180448, a prototype mitoK(ATP) channel opener, and the role of salvage kinases, in the rat model of global ischemia and reperfusion heart injury.
Lee JH; Jung IS; Lee SH; Yang MK; Hwang JH; Lee HD; Cho YS; Song MJ; Yi KY; Yoo SE; Kwon SH; Kim B; Lee CS; Shin HS
Arch Pharm Res; 2007 May; 30(5):634-40. PubMed ID: 17615684
[TBL] [Abstract][Full Text] [Related]
25. Both metabolic inhibition and mitochondrial K(ATP) channel opening are myoprotective and initiate a compensatory sarcolemmal outward membrane current.
Irie H; Gao J; Gaudette GR; Cohen IS; Mathias RT; Saltman AE; Krukenkamp IB
Circulation; 2003 Sep; 108 Suppl 1():II341-7. PubMed ID: 12970257
[TBL] [Abstract][Full Text] [Related]
26. Hyperthermia-induced cardioprotection is potentiated by ischemic postconditioning in rats.
Murozono Y; Takahashi N; Shinohara T; Ooie T; Teshima Y; Hara M; Saikawa T; Yoshimatsu H
Exp Biol Med (Maywood); 2009 May; 234(5):573-81. PubMed ID: 19234055
[TBL] [Abstract][Full Text] [Related]
27. The mitochondrial K(ATP) channel opener BMS-191095 reduces neuronal damage after transient focal cerebral ischemia in rats.
Mayanagi K; Gáspár T; Katakam PV; Kis B; Busija DW
J Cereb Blood Flow Metab; 2007 Feb; 27(2):348-55. PubMed ID: 16736040
[TBL] [Abstract][Full Text] [Related]
28. Role of mitochondrial and sarcolemmal K(ATP) channels in ischemic preconditioning of the canine heart.
Sanada S; Kitakaze M; Asanuma H; Harada K; Ogita H; Node K; Takashima S; Sakata Y; Asakura M; Shinozaki Y; Mori H; Kuzuya T; Hori M
Am J Physiol Heart Circ Physiol; 2001 Jan; 280(1):H256-63. PubMed ID: 11123240
[TBL] [Abstract][Full Text] [Related]
29. Cardioprotective effect of diazoxide is mediated by activation of sarcolemmal but not mitochondrial ATP-sensitive potassium channels in mice.
Suzuki M; Saito T; Sato T; Tamagawa M; Miki T; Seino S; Nakaya H
Circulation; 2003 Feb; 107(5):682-5. PubMed ID: 12578868
[TBL] [Abstract][Full Text] [Related]
30. Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide.
Mocanu MM; Maddock HL; Baxter GF; Lawrence CL; Standen NB; Yellon DM
Circulation; 2001 Jun; 103(25):3111-6. PubMed ID: 11425777
[TBL] [Abstract][Full Text] [Related]
31. Preconditioning by mitochondrial ATP-sensitive potassium channel openers: An effective approach for improving the preservation of heart transplants.
Kevelaitis E; Oubénaïssa A; Peynet J; Mouas C; Menasché P
Circulation; 1999 Nov; 100(19 Suppl):II345-50. PubMed ID: 10567327
[TBL] [Abstract][Full Text] [Related]
32. Infarct size limitation by nicorandil: roles of mitochondrial K(ATP) channels, sarcolemmal K(ATP) channels, and protein kinase C.
Tsuchida A; Miura T; Tanno M; Sakamoto J; Miki T; Kuno A; Matsumoto T; Ohnuma Y; Ichikawa Y; Shimamoto K
J Am Coll Cardiol; 2002 Oct; 40(8):1523-30. PubMed ID: 12392845
[TBL] [Abstract][Full Text] [Related]
33. Glyburide-reversible cardioprotective effects of BMS-180448: functional and energetic considerations.
Grover GJ; Sleph PG; Dzwonczyk S; Malone HJ; Behling RW
J Cardiovasc Pharmacol; 1997 Jan; 29(1):28-38. PubMed ID: 9007667
[TBL] [Abstract][Full Text] [Related]
34. Adenosine-induced late preconditioning in mouse hearts: role of p38 MAP kinase and mitochondrial K(ATP) channels.
Zhao TC; Hines DS; Kukreja RC
Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1278-85. PubMed ID: 11179074
[TBL] [Abstract][Full Text] [Related]
35. Cardioprotective effects of mitochondrial KATP channels activated at different time.
Wei K; Min S; Long C
Chin Med J (Engl); 2004 May; 117(5):647-51. PubMed ID: 15161527
[TBL] [Abstract][Full Text] [Related]
36. Diazoxide acts more as a PKC-epsilon activator, and indirectly activates the mitochondrial K(ATP) channel conferring cardioprotection against hypoxic injury.
Kim MY; Kim MJ; Yoon IS; Ahn JH; Lee SH; Baik EJ; Moon CH; Jung YS
Br J Pharmacol; 2006 Dec; 149(8):1059-70. PubMed ID: 17043673
[TBL] [Abstract][Full Text] [Related]
37. Preconditioning limits mitochondrial Ca(2+) during ischemia in rat hearts: role of K(ATP) channels.
Wang L; Cherednichenko G; Hernandez L; Halow J; Camacho SA; Figueredo V; Schaefer S
Am J Physiol Heart Circ Physiol; 2001 May; 280(5):H2321-8. PubMed ID: 11299237
[TBL] [Abstract][Full Text] [Related]
38. Antidiabetic drug pioglitazone protects the heart via activation of PPAR-gamma receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction.
Yasuda S; Kobayashi H; Iwasa M; Kawamura I; Sumi S; Narentuoya B; Yamaki T; Ushikoshi H; Nishigaki K; Nagashima K; Takemura G; Fujiwara T; Fujiwara H; Minatoguchi S
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1558-65. PubMed ID: 19286954
[TBL] [Abstract][Full Text] [Related]
39. GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways.
Vigneron F; Dos Santos P; Lemoine S; Bonnet M; Tariosse L; Couffinhal T; Duplaà C; Jaspard-Vinassa B
Cardiovasc Res; 2011 Apr; 90(1):49-56. PubMed ID: 21233250
[TBL] [Abstract][Full Text] [Related]
40. BMS-191095, a cardioselective mitochondrial K(ATP) opener, inhibits human platelet aggregation by opening mitochondrial K(ATP) channels.
Cho MR; Park JW; Jung IS; Yi KY; Yoo SE; Chung HJ; Yun YP; Kwon SH; Shin HS
Arch Pharm Res; 2005 Jan; 28(1):61-7. PubMed ID: 15742810
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
